Reducing radiation area for stage IIb cervical cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests whether giving radiation to a smaller area of the pelvis is enough to treat stage IIb cervical cancer, while sparing more healthy tissue. It may help reduce side effects and improve your quality of life during and after treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 50 and 75 years old.
- You need a new cervical cancer diagnosis that is a type called squamous cell carcinoma, and you must not have had surgery or chemotherapy yet.
- Your cancer must be stage IIb (the tumor is smaller than 4 cm) and you must be positive for high-risk HPV.
- You should be in good everyday health (able to care for yourself) and have a life expectancy of more than 6 months.
- You must not have had radiation to the pelvic area or a hysterectomy (removal of the uterus) in the past.
- You must be free of serious health problems like heart failure, kidney failure, or other cancers treated in the past 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a shorter course of radiation combined with chemotherapy and brachytherapy (internal radiation) for cervical cancer that has not spread widely. It aims to make treatment more efficient while still being effective.
This Phase 3 trial studies how best to treat intermediate-risk cervical cancer using radical surgery, with or without additional radiation after surgery. It may help find which approach lowers the chance the cancer comes back for patients with certain tumor risk features.
This trial tests a type of radiation that adapts to your body changes during treatment for cervical cancer. It aims to improve accuracy and reduce side effects.
This Phase 2 trial looks at a “split” (hypo-fractionated) schedule of chemotherapy plus radiation for cervical cancer, followed by brachytherapy. It aims to see how well the treatment works and what side effects happen, especially toxicity.
This trial tests a feasibility (“can it be done safely?”) approach that delivers radiation in a shorter schedule for some cervical cancer patients. It also uses weekly cisplatin chemotherapy and includes a radiation procedure called brachytherapy to improve treatment effectiveness.
This trial is testing a combination of standard chemotherapy and radiation delivered to the pelvis, followed by an internal radiation treatment guided by CT scans. The goal is to improve treatment for locally advanced cervical cancer while potentially reducing side effects.
Hear when a new Stage IIb Cervical Cancer Radical Radiotherapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.